Clinical trials
Phase 1/2 Sepsis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Unknown status | 4 |
| Terminated | 3 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ain Shams University | 2 |
| Beth Israel Deaconess Medical Center | 2 |
| University of Florida | 2 |
| Zhujiang Hospital | 2 |
| Ascension Health | 1 |
| AstraZeneca | 1 |
| Austin Health | 1 |
| Belfast Health and Social Care Trust | 1 |
| CHA University | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sepsis | 35 |
| Shock, Septic | 12 |
| Acute Kidney Injury | 4 |
| COVID-19 | 3 |
| Critical Illness | 3 |
| Acute Lung Injury | 2 |
| Burns | 2 |
| Inflammation | 2 |
| Respiratory Distress Syndrome | 2 |
| Systemic Inflammatory Response Syndrome | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.